Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v12-FR
Language English French
Date Updated 2019-06-19 2019-06-18
Drug Identification Number 02362171 02362171
Brand name PATADAY PATADAY
Common or Proper name PATADAY 0.3% SOLN 2.5ML PATADAY 0.3% SOLN 2.5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients OLOPATADINE OLOPATADINE
Strength(s) 0.2% 0.2%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 2.5ML 2.5ML
ATC code S01GX S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-05-10 2019-05-10
Actual start date 2019-05-15 2019-05-15
Estimated end date 2019-06-26 2019-06-26
Actual end date 2019-06-18 2019-06-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Potential olopatadine treatment alternatives available: Pazeo, Patanol, generics Potential olopatadine treatment alternatives available: Pazeo, Patanol, generics
Health Canada comments